Inhaled drug shows safety in long-term use for rare lung-heart condition
NCT ID NCT05649722
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 30 times
Summary
This study checked the long-term safety of an inhaled powder drug (treprostinil palmitil) in 31 people with pulmonary hypertension caused by interstitial lung disease. Participants had already completed a previous study of the same drug. The main goal was to see how many had side effects over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARG001
Rosario, Santa Fe Province, S2013KDS, Argentina
-
ARG003
Autonomus City of Buenos Aires, Buenos Aires, C1280AEB, Argentina
-
AUS005
Macquarie Park, New South Wales, 2109, Australia
-
BEL002
Liège, 4000, Belgium
-
ESP003
Palma, Balearic Islands, 07120, Spain
-
ESP005
Barcelona, 08907, Spain
-
ESP007
Oviedo, Principality of Asturias, 33011, Spain
-
ESP009
Santiago de Compostela, Galicia, 15706, Spain
-
ESP010
Barcelona, 8035, Spain
-
GBR001
Sheffield, South Yorkshire, S10 2JF, United Kingdom
-
GBR003
Clydebank, Glasgow, G81 4DY, United Kingdom
-
GER001
Dresden, Saxony, 01307, Germany
-
GER002
Berlin, 13125, Germany
-
GER003
Essen, North Rhine-Westphalia, 45239, Germany
-
GER004
München, Bavaria, 81377, Germany
-
GER006
Heidelberg, Baden-Wurttemberg, 69126, Germany
-
GER010
Giessen, Hesse, 35392, Germany
-
GER012
Berlin, 14050, Germany
-
ITA001
Palermo, Sicily, 90127, Italy
-
ITA002
Monza, Lombardy, 20900, Italy
-
ITA003
Naples, 80131, Italy
-
ITA004
Milan, Lombardy, 20123, Italy
Conditions
Explore the condition pages connected to this study.